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Early mortality (EM) after nonfenestrated Fontan operation (NF) has been
reported to be higher for young pts, specifically those less than 4 yrs old.
In our recent experience, overall EM has decreased markedly. In order to
determine if the risk of EM after NF is still significantly increased for young
pts, we reviewed all 839 pts who had NF at our institution between 1973-92.
During this period, 123 (15%) pts younger than age 4 yrs had a NF. EM for
this group of pts was 22/123 (18%). During the last 20 yrs, EM after NF for
pts younger than 4 yrs has decreased progressively at our institution: 1973-
77 = 50%, 1978-82 = 32%, 1983-86 = 20%, 1987-92 = 12% (p < 0.04). In
the 3 early time periods, EM was consistently greater in pts younger than 4
yrs than in older pts. However, in our recent experience (1987-92), EM after
NF for pts younger than 4 yrs [8/69 (12%)] is not significantly different from
EM after NF for older pts [22/270 (8%)). Many factors have contributed to the
improved early outcome in young pts. Among these are the fact that in our
earlier experience (1973-86), pts younger than 4 yrs frequently had NF on
a non-elective basis [20/54 137%)] due to progressive clinical deterioration.
Also, in the more recent period, selection criteria for NF have become more
stringent and staging operations (i.e. cavopulrnonaryconnections) have been
more widely utilized.
Several institutions have advocated atrial baffle fenestration to improve
survival for high-risk Fontan pts including those less than 4 yrs old. However,
our results with nonfenestrated Fontan operations indicate that with careful
pt selection, children younger than age 4 yrs, have an operative risk which is
not only improved, but similar to that observed in older pts. Therefore, any
technical modification of the Fontan procedure must be evaluated in light of
these recent improved results.
pre-existing CHB and 1 pt following VSD enlargement and 1 pt with SLL. At a
fOllOW-Up of 1 to 22 months (median 11) there were no significant new arry-
thmias, one pt required reoperation for thrombosis of left pulmonary artery
and 3 pts required pericardioperitoneal window for effusion, and one pt died
following re-do sternotomy.
ECCF is an excellent alternative to LTF with good early and midterm results.
However, late follow up is essential to evaluate its potential advantages.
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An Institutional Experience with Second and Third
Stage Palliative Procedures for Hypoplastic Left
Heart Syndrome: The Impact of the Bidirectional
Cavopulmonary Shunt
Joseph M. Forbess, Nancy Cook, Alain Serraf, Redmond P. Burke, John E. Mayer,
Jr., Richard A. Jonas. Children's Hospital, Boston, MA
We reviewed 71 consecutive pts who underwent stage II and III operations
fOllowing stage I palliation for hypoplastic left heart syndrome (HLHS) at
our institution since 1983, 6 surgeons participated in the care of these pts.
Follow-up is 97% complete. We examined 17 potential risk factors for mor-
tality, including preoperative anatomic and physiologic factors, and proce-
dural features of the stage II operation. Multivariate analysis revealed that
the only significant risk factor for stage II mortality was the performance of a
non-fenestrated completion Fontan procedure (p < 0.001). There were 9 hos-
pital deaths (69%) in the 13 pts undergoing the Fontan procedure at stage II.
In contrast. 49 pts underwent bidirectional cavopulmonary shunting (47) or
hemi-Fontan procedure(2) as an intermediate step to the Fontan procedure
with 4 (8%) early deaths. The first bidirectional cavopulmonary shunt was
performed in this population in 1988. Median age at this stage II procedure
was 8.4 months. Surgical augmentation of the pulmonary arteries was per-
formed in 18 (37%) pts at the time of stage II surgery and was not associated
with increased operative risk. Also, HLHS anatomic subtype was not a risk
factor for stage II mortality or pre-stage III attrition. There have been 2 (4%) in-
termediate deaths prior to the performance of a stage III procedure, which at
our institution is the fenestrated Fontan procedure. This has been performed
in 25 pts at a median age of 30 months with 1 early death and no mortality at
a median fOllOW-Up of 22 months. There are presently 34 HLHS pts who have
modified Fontan anatomy following a course of surgical palliation performed
entirely at this institution. FOllOW-Up in this group ranges up to 92 months,
with a median of 28 months. 33 of these patients are NYHA class 1 or 2. 2
pts have required pacemaker implantation, but there have otherwise been
no surgical reinterventions in pts who have completed palliation. We con-
clude that the incorporation of the bidirectional cavopulmonary shunt into a
course of surgical palliation for HLHS has dramatically reduced mortality in
this challenging group of pts, allowing them to undergo the modified fenes-
trated Fontan procedure with low operative mortality and good intermediate
outcome.
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Lateral tunnel modification of Fontan procedure (LTF) is widely practiced
based on the advantages of better hydrodynamics and fewer atrial compli-
cations. We have routinely employed extra-cardiac conduit Fontan (ECCF)
because of the following potential advantages: 1) it avoids the atrium com-
pletely in the Fontan path, 2) it can be performed on a perfused beating heart
without cross clamping the aorta thereby completely avoiding ischemic in-
sult to the myocardium, and 3) it provides improved laminar flow. From 7/92
to 8/94, 35 patients (pts) aged 1.7 to 44.2 years (median 6.52 years) under-
went ECCF, including revision of a failing Fontan to ECCF in 7 pts. Principal di-
agnoses were tricuspid atresia (n: 14), double inlet ventricle (n: 10), corrected
transposition of the great arteries (SLL) with left atrioventricular valve atresia
(n:4) and other forms of single ventricle in the rest (n:7). An avenge of 2.3
previous operations were done per patient. Surgical procedure included ex-
tracardiac total cavopulmonary anastomosis using a ePTFE conduit (16 to 22
mm) or a nonvalved aortic homograft conduit (18 to 25 mm). Pop off fenestra-
tion between the conduit and the atrium was provided by a 4 - 5 mm ePTFE
tube graft (n:20) or a side to side anastomosis with the atrium In:4). Addi-
tional surgical procedures included ligation of systemic shunts (n: 17), pul-
monary arterioplasty In:15), enlargement of bulboventricular foramen (n:4),
mitral valve repair (n:1), and cryoablation of junctional ectopic focus (n:1).
The only early death in the series was a pt of a failing Fontan with chronic
massive ascites, pleural effusions, and cachexia who was not a candidate
for heart transplant due to social reasons. Early complications included pro-
longed pleural and/or pericardial effusion in 6/34 pts (18%) and transient ar-
rythmias in 6 pts. Permanent pacemaker was implanted in 4 pts: 2 pts with
Stacey E. Drant, Vivekanand Allada, Roberta G. Williams. UClA Medical Center. Las
Angeles, CA
In patients with pulmonary atresia and intact ventricular septum (PAlIVSl. the
presence of right ventricular to coronary communications (RVCC) dictates
surgical management (right ventricular (RV) decompression). Previously, tri-
cuspid valve annulus size-Z score (TV-Zl. and RV morphology have been used
to predict the presence of RVCC. We hypothesize that pulmonary infundibu-
lar diameter better predicts the presence of RVCC than TV-Z score.
Methods: From 2/91 to 7/94, 24 neonates with PAlIVS referred to our in-
stitution were studied (6 of which were prospectively evaluated). Four were
excluded: 1 with associated Ebstein's anomaly and 3 with incomplete data.
In the remaining 20 pts., echocardiographic measurements of the TV annu-
lus and infundibular diameter were made, and angiograms were reviewed for
the presence and extent of RVCC. Statistical analysis was performed using
a two tailed student's t test.
Resu/ts: Eleven pts with RVCC had significantly smaller infundibulardiame-
ter(2.3 ± 07 mm)than nine ptswithout RVCC(6.5 ± 1.6 mm), P < 0.0001. All
patient with RVCC had infundibular diameter < 3.4 mm. All patients without
RVCC had infundibular diameter> 5.0 mm. While, the TV Z-score was also
significantly smaller: -3.52 ±1.3 vs. -0.76 ± 1.0, respectively, p < 0.001,
there was significant overlap between the groups. In all six cases studied
prospectively, the presence of RVCC was predicted correctly, using the in-
fundibular diameter.
Conclusion: The infundibular diameter measured by Echo accurately pre-
dicts the presence of RV-coronary communications in neonates with PAlIVS.
This method better distinguishes the presence or absence of RVCC than TV-
Z score.
